These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36449257)

  • 1. Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease.
    Alexandre AF; Morga A; Thomas C; Krucien N; Tervonen T; Jiletcovici A; Marsh K
    Adv Ther; 2023 Feb; 40(2):641-657. PubMed ID: 36449257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
    Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
    Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.
    Natale P; Palmer SC; Jaure A; Hodson EM; Ruospo M; Cooper TE; Hahn D; Saglimbene VM; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013751. PubMed ID: 36005278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Discrete Choice Study of Patient Preferences for Dialysis Modalities.
    Walker RC; Morton RL; Palmer SC; Marshall MR; Tong A; Howard K
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):100-108. PubMed ID: 29051145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis patients' preferences for the management of anemia.
    Hauber B; Caloyeras J; Posner J; Brommage D; Tzivelekis S; Pollock A
    BMC Nephrol; 2017 Jul; 18(1):253. PubMed ID: 28750609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.
    Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Roubert B; Nolen JG; Roger SD;
    Nephrol Dial Transplant; 2014 Nov; 29(11):2075-84. PubMed ID: 24891437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
    Kalra PA; Bhandari S; Saxena S; Agarwal D; Wirtz G; Kletzmayr J; Thomsen LL; Coyne DW
    Nephrol Dial Transplant; 2016 Apr; 31(4):646-55. PubMed ID: 26250435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
    Eckardt KU; Agarwal R; Farag YM; Jardine AG; Khawaja Z; Koury MJ; Luo W; Matsushita K; McCullough PA; Parfrey P; Ross G; Sarnak MJ; Vargo D; Winkelmayer WC; Chertow GM
    Nephrol Dial Transplant; 2021 Nov; 36(11):2039-2048. PubMed ID: 33188693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.
    Minutolo R; Locatelli F; Gallieni M; Bonofiglio R; Fuiano G; Oldrizzi L; Conte G; De Nicola L; Mangione F; Esposito P; Dal Canton A;
    Nephrol Dial Transplant; 2013 Dec; 28(12):3035-45. PubMed ID: 24145459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non-dialysis-dependent chronic kidney disease-related anaemia in Japan.
    Mishina S; Waratani M; Onozawa S; Okumura H; Ito Y; Yasuda Y
    Nephrology (Carlton); 2023 Aug; 28(8):446-455. PubMed ID: 37161826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
    Iimori S; Naito S; Noda Y; Nishida H; Kihira H; Yui N; Okado T; Sasaki S; Uchida S; Rai T
    Nephrology (Carlton); 2015 Sep; 20(9):601-8. PubMed ID: 25917812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
    Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
    Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
    Provenzano R; Szczech L; Leong R; Saikali KG; Zhong M; Lee TT; Little DJ; Houser MT; Frison L; Houghton J; Neff TB
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1190-1200. PubMed ID: 34362786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study.
    Morton RL; Snelling P; Webster AC; Rose J; Masterson R; Johnson DW; Howard K
    Am J Kidney Dis; 2012 Jul; 60(1):102-11. PubMed ID: 22417786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis.
    Zheng L; Tian J; Liu D; Zhao Y; Fang X; Zhang Y; Liu Y
    Br J Clin Pharmacol; 2022 Mar; 88(3):919-932. PubMed ID: 34428860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences of Patients With Chronic Kidney Disease for Invasive Versus Conservative Treatment of Acute Coronary Syndrome: A Discrete Choice Experiment.
    Wilson TA; Hazlewood GS; Sajobi TT; Wilton SB; Pearson WE; Connolly C; Javaheri PA; Finlay JL; Levin A; Graham MM; Tonelli M; James MT
    J Am Heart Assoc; 2023 Mar; 12(6):e028492. PubMed ID: 36892063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
    Pisani A; Riccio E; Sabbatini M; Andreucci M; Del Rio A; Visciano B
    Nephrol Dial Transplant; 2015 Apr; 30(4):645-52. PubMed ID: 25395392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.